Nambling, Alicia .
HRN: 04-88-65 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/25/2025
CEFTRIAXONE 1G (VIAL)
01/25/2025
01/31/2025
IV
2g
OD
Uti
Waiting Final Action